Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-09

Clinical Trial Update: Effects of Parathyroid Hormone in Men With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of parathyroid hormone in men with osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED